Amy C Sherman

2.9k total citations · 1 hit paper
41 papers, 908 citations indexed

About

Amy C Sherman is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Amy C Sherman has authored 41 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 11 papers in Immunology. Recurrent topics in Amy C Sherman's work include SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (7 papers) and Influenza Virus Research Studies (5 papers). Amy C Sherman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), COVID-19 Clinical Research Studies (7 papers) and Influenza Virus Research Studies (5 papers). Amy C Sherman collaborates with scholars based in United States, Canada and United Kingdom. Amy C Sherman's co-authors include Anita Kohli, Shyam Kottilil, Ashton A. Shaffer, Sanjat Kanjilal, Daniel A. Solomon, Lindsey R. Baden, Michaël Desjardins, Nadine Rouphael, Kenneth E. Sherman and David R. Walt and has published in prestigious journals such as New England Journal of Medicine, JAMA and Clinical Infectious Diseases.

In The Last Decade

Amy C Sherman

35 papers receiving 889 citations

Hit Papers

Treatment of Hepatitis C 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment of Hepatitis C
    2014 334 citations Anita Kohli, Amy C Sherman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy C Sherman United States 12 475 352 340 131 106 41 908
Iwona Mozer‐Lisewska Poland 16 281 0.6× 210 0.6× 314 0.9× 192 1.5× 89 0.8× 101 764
Alexandra Ducancelle France 19 624 1.3× 283 0.8× 324 1.0× 65 0.5× 125 1.2× 59 951
Marialuisa Partisani France 15 351 0.7× 598 1.7× 146 0.4× 80 0.6× 51 0.5× 38 1.1k
Арег А. Тотолян Russia 13 212 0.4× 322 0.9× 128 0.4× 150 1.1× 89 0.8× 205 779
Benoît Callendret Netherlands 20 893 1.9× 751 2.1× 432 1.3× 299 2.3× 131 1.2× 49 1.6k
Krzysztof Tomasiewicz Poland 20 374 0.8× 424 1.2× 319 0.9× 44 0.3× 77 0.7× 94 981
Mawuena Binka Canada 17 595 1.3× 328 0.9× 534 1.6× 79 0.6× 73 0.7× 53 947
Duaa W. Al‐Sadeq Qatar 16 198 0.4× 569 1.6× 119 0.3× 73 0.6× 129 1.2× 35 998
Antje Knöll Germany 21 454 1.0× 290 0.8× 323 0.9× 61 0.5× 259 2.4× 43 1.1k
Huiping Yan China 12 386 0.8× 452 1.3× 200 0.6× 394 3.0× 204 1.9× 48 1.0k

Countries citing papers authored by Amy C Sherman

Since Specialization
Citations

This map shows the geographic impact of Amy C Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C Sherman more than expected).

Fields of papers citing papers by Amy C Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C Sherman. The network helps show where Amy C Sherman may publish in the future.

Co-authorship network of co-authors of Amy C Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C Sherman. A scholar is included among the top collaborators of Amy C Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C Sherman. Amy C Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherman, Amy C, Glenda Gray, Bin Cao, et al.. (2025). Acute SARS-CoV-2 infection. Nature Reviews Disease Primers. 11(1). 75–75.
2.
Angelidou, Asimenia, Amy C Sherman, Cameron McLoughlin, et al.. (2025). Product and trial design considerations on the path towards a vaccine to combat opioid overdose. npj Vaccines. 10(1). 35–35. 2 indexed citations
3.
Little, Jessica S, et al.. (2024). Molecular Diagnostics for Invasive Molds: From Lab to Bedside. Clinics in Laboratory Medicine. 45(1). 27–40. 1 indexed citations
4.
Amodio, Donato, Asimenia Angelidou, Nicola Cotugno, et al.. (2024). Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference. Vaccine. 43(Pt 2). 126477–126477.
5.
Sherman, Amy C, Simon D. van Haren, Ella Borberg, et al.. (2024). Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. Vaccine. 42(22). 126054–126054. 3 indexed citations
6.
Kakoullis, Loukas, Andy Kim, Bridget Yates, et al.. (2023). 2707. Complications of Babesiosis in Immunocompromised and Asplenic/Hyposplenic Patients. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
7.
Kokogho, Afoke, Trevor A. Crowell, Sonya Davey, et al.. (2023). SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients. Open Forum Infectious Diseases. 10(7). ofad349–ofad349. 1 indexed citations
8.
Little, Jessica S, Sonya Davey, Guohai Zhou, et al.. (2023). Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients. Transplantation and Cellular Therapy. 29(6). 398.e1–398.e5. 11 indexed citations
9.
Desjardins, Michaël, Jonathan Krauß, Jane A. Kleinjan, et al.. (2023). Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors.. PubMed. 142(2). 202–209. 1 indexed citations
10.
Sherman, Amy C, Chi‐An Cheng, Zoe Swank, et al.. (2023). Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 29(5). 337.e1–337.e5. 5 indexed citations
11.
Howard‐Anderson, Jessica, Teresa Smith, Amy C Sherman, et al.. (2022). Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study. Infection Control and Hospital Epidemiology. 43(11). 1664–1671. 5 indexed citations
12.
Sherman, Amy C, Michaël Desjardins, & Lindsey R. Baden. (2021). Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection). Clinics in Laboratory Medicine. 42(1). 111–128. 10 indexed citations
13.
Sherman, Amy C, Jennifer O. Spicer, Julia A. Messina, et al.. (2021). Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers. Transplant Infectious Disease. 23(4). e13636–e13636. 16 indexed citations
14.
15.
Sherman, Amy C, Xiaoyan Lu, Eileen Schneider, et al.. (2021). Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection. Open Forum Infectious Diseases. 8(3). ofab092–ofab092. 5 indexed citations
16.
Sherman, Amy C, Ahmed Babiker, James P. Steinberg, et al.. (2020). The Effect of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of 2 Large Metropolitan Centers in the United States. Clinical Infectious Diseases. 72(5). e154–e157. 41 indexed citations
17.
Sherman, Amy C, Aneesh K. Mehta, Neal W. Dickert, Evan J. Anderson, & Nadine Rouphael. (2019). The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology. Frontiers in Cellular and Infection Microbiology. 9. 107–107. 54 indexed citations
18.
Sherman, Amy C & Kenneth E. Sherman. (2015). Extrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM. Current HIV/AIDS Reports. 12(3). 353–361. 30 indexed citations
19.
Sherman, Amy C, Nirupama Trehanpati, Marybeth Daucher, et al.. (2012). Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir. AIDS Research and Human Retroviruses. 29(4). 665–672. 27 indexed citations
20.
Kohli, Anita, Jun Yang, Rodney S. Russell, et al.. (2012). Distinct and overlapping genomic profiles and antiviral effects of Interferon‐λ and ‐α on HCV‐infected and noninfected hepatoma cells. Journal of Viral Hepatitis. 19(12). 843–853. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iwona Mozer‐Lisewska Breakdown of academic impact, for papers by Alexandra Ducancelle Breakdown of academic impact, for papers by Marialuisa Partisani Breakdown of academic impact, for papers by Арег А. Тотолян Breakdown of academic impact, for papers by Benoît Callendret Breakdown of academic impact, for papers by Krzysztof Tomasiewicz Breakdown of academic impact, for papers by Mawuena Binka Breakdown of academic impact, for papers by Duaa W. Al‐Sadeq Breakdown of academic impact, for papers by Antje Knöll Breakdown of academic impact, for papers by Huiping Yan
Rankless by CCL
2026